These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4221951)

  • 21. [Evaluation of screening for cervix carcinoma].
    Gaasbeek Janzen HM; Gimbrère CH; Eliel MR
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):266-7. PubMed ID: 8433767
    [No Abstract]   [Full Text] [Related]  

  • 22. Results of longterm hospital based cytological screening in asymptomatic women.
    Misra JS; Singh U
    Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morphology and development of 106 cervical atypias observed during 12,300 pregnancies].
    de Brux J; Panopoulos C; Coupez F
    Rev Fr Gynecol Obstet; 1971; 66(11):671-9. PubMed ID: 5148541
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of screening examinations on stage distributions of cervical carcinoma at a gynecological department ].
    Anderl P; Ledermair O
    Wien Med Wochenschr; 1982 Jun; 132(11):241-3. PubMed ID: 7123963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of morbidity and mortality from cancer of the cervix uteri in Puerto Rico.
    Martínez I
    Bol Asoc Med P R; 1984 Mar; 76(3):100-6. PubMed ID: 6586182
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of cervical cancer.
    Denny L
    Reprod Health Matters; 2008 Nov; 16(32):18-31. PubMed ID: 19027619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A mass survey of the incidence of cervix cancer].
    Thorarinsson A; Jensson O; Bjarnason O
    Nord Med; 1967 Dec; 78(49):1608-11. PubMed ID: 6073716
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prophylaxis and early detection of cervix carcinoma].
    Held E
    Schweiz Rundsch Med Prax; 1970 Jul; 59(28):1021-9. PubMed ID: 5512823
    [No Abstract]   [Full Text] [Related]  

  • 30. Results of cytologic mass screening in the Federal Republic of Germany.
    Soost HJ; Bockmühl B; Zock H
    Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early case finding of cervix carcinoma in primary care].
    Moens GF
    Arch Belg; 1983; 41(5-6):249-54. PubMed ID: 6670888
    [No Abstract]   [Full Text] [Related]  

  • 32. [What is the reason for non-participation in mass screening of cervix neoplasms?].
    Fortelius P; Haapoja H; Hakulinen T
    Duodecim; 1974; 90(8):597-601. PubMed ID: 4411522
    [No Abstract]   [Full Text] [Related]  

  • 33. Why do women still develop cancer of the cervix despite the existence of a national screening programme?
    Brinkmann D; Gladman MA; Norman S; Lawton FG
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):123-4. PubMed ID: 15734097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Project: screen South Africa.
    Knight B
    Diagn Cytopathol; 2005 Nov; 33(5):356-8. PubMed ID: 16240404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS; Gupta HP; Das V
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systematic screening for cancer of the uterine cervix (epidemiologic aspects)].
    Campion J; Flamant R
    Bull Inst Natl Sante Rech Med; 1966; 21(5):977-94. PubMed ID: 5976404
    [No Abstract]   [Full Text] [Related]  

  • 38. Mortality rates from carcinoma of the uterine cervix in Arkansas: 1950-1969.
    Steinkamp RC
    J Ark Med Soc; 1975 Mar; 71(10):312-3. PubMed ID: 123903
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bleeding disorders. Screening for cancer of the uterine cervix].
    Kirt B
    Sygeplejersken; 1993 Jun; 93(26):12. PubMed ID: 8140514
    [No Abstract]   [Full Text] [Related]  

  • 40. Breast and cervical carcinoma: the correlation of activity limitations and rurality with screening, disease incidence, and mortality.
    Schootman M; Fuortes LJ
    Cancer; 1999 Sep; 86(6):1087-94. PubMed ID: 10491538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.